Biosimilars Will Lift Sandoz Following Q2 Sales Slump

Reversal Of COVID-19 Impact Hurts Top Line

 
• By Dean Rudge
  
Weight_Lifting
Sandoz is eyeing a lift from biosimilars in H2 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products